Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine for behavioural and emotional problems and executive dysfunction after acquired frontal brain injury
2012-005723-33Phase 4Terminated
- Sponsor
- GGZ Oost Brabant
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of amantadine in Organic personality disorder, emotional lability (PBA), apathy and 3 more, sponsored by GGZ Oost Brabant. Primary endpoints: Behavioural disturbance due to brain injury and Impairment in executive functioning. Started Oct 2014; status: terminated.
02
Drugs
amantadine
03
Conditions
Organic personality disorderemotional lability (PBA)apathyintermittent explosive disorder (IED)Dysexecutive Syndrome (DES)
Beyond the preview
Go deeper on 2012-005723-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005723-33.